Survival analysis of glioma patients in the CGGA data set showed that the overall survival (OS) of patients with high SECTM1 expression was significantly shorter than that of patients with low SECTM1 expression (Figure 2A). The gene discussed is SECTM1; the disease is central nervous system cancer.